logo
The 3 Best Hotels in Hong Kong of 2025

The 3 Best Hotels in Hong Kong of 2025

Hong Kong dazzles with its one-of-a-kind fusion of tradition and modernity. The contemporary skyline full of high-rises contrast with its busy street markets and historic temples, while world-class museums and galleries draw culture seekers from around the world. But this financial hub of Asia, with more than 7 million residents, also offers another major attraction: several of the best hotels in the world, known for their outstanding hospitality and cinematic Victoria Harbour views. It's no surprise, then, that the Hong Kong hotels recognized in this year's World's Best Awards survey stood out for more than just design—they deliver the kind of service, guest experiences, restaurants, and a sense of place that reflects the city's vibrant identity. Every year for our World's Best Awards survey, T+L asks readers to weigh in on travel experiences around the globe—to share their opinions on the top hotels, resorts, cities, islands, cruise ships, spas, airlines, and more. Nearly 180,000 T+L readers completed the 2025 survey. A total of more than 657,000 votes were cast across over 8,700 properties (hotels, cities, cruise lines, etc.). Hotels were classified as either resort hotel, city hotel, inn, or safari lodge based on their location and amenities, and they were specifically rated on the criteria below: Rooms/facilities Location Service Food Value For each characteristic, respondents could choose a rating of excellent, above average, average, below average, or poor. The final scores are averages of these responses.
View of the Hong Kong skyline from a Classic Harbourview Room at the Regent Hong Kong.
Since reopening after three years of pandemic closure, Hong Kong has come roaring back as a destination for readers, who have enthusiastically returned to their favorite hotels (or to scope out new ones). The waterfront, 413-room Rosewood Hong Kong is this year's runner-up, and only debuted in 2019. It earned its spot thanks to fantastic Victoria Harbour views, an outdoor infinity pool, world-class dining (including Michelin-starred restaurants Chaat, which specializes in Indian cuisine, and The Legacy House, which serves Cantonese classics), and the Asaya holistic wellness center.
Claiming the No. 3 spot is the 513-room Conrad Hong Kong in the city's Admiralty district, directly above the Pacific Place shopping mall, with proximity to the 20-acre Hong Kong Park and the Peak Tram (the funicular railway that transports riders up into the hills of the island). This year's winner was described by one reader as having 'incredible service, which makes it feel like home.' Read on to find out more.
Regent Hong Kong Panoramic views from the Presidential Suite's living room at the Regent Hong Kong.
Perched on the edge of Victoria Harbour in the Kowloon area of Hong Kong, this year's winner (for the second year) offers a front-row seat to one of the world's most iconic skylines. Following a sweeping transformation two years ago, the property is now known for blending a sleek, contemporary aesthetic with unmatched service. One reader, noting the sophisticated interiors and attentive staff, mentioned that 'each visit brings me a sense of peace, thanks to the welcoming atmosphere. The staff consistently demonstrates friendliness and helpfulness.' Another praised Regent's 'absolutely breathtaking' views, and raved that 'the service was exceptional. Plus, the location couldn't be better—right next to a high-end shopping mall. It's the perfect spot for a memorable experience.'
Each visit brings me a sense of peace, thanks to the welcoming atmosphere. The staff consistently demonstrates friendliness and helpfulness.
— T+L Reader
1. Regent Hong Kong
Reader score: 99.10
2. Rosewood Hong Kong
Reader score: 94.13
3. Conrad Hong Kong
Reader score: 93.60
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This New Hot Springs Near Zion National Park Has Over 50 Geothermal Pools and Stunning Rock Views
This New Hot Springs Near Zion National Park Has Over 50 Geothermal Pools and Stunning Rock Views

Yahoo

time23 minutes ago

  • Yahoo

This New Hot Springs Near Zion National Park Has Over 50 Geothermal Pools and Stunning Rock Views

Zion Canyon Hot Springs just opened near Zion National Park with over 50 geothermal pools inspired by global destinations. It was built to revive public access to the area's healing waters and create a top-tier hot springs retreat in the U.S. can now soak in Iceland, Japan, and New Zealand—all in the Utah desert. Just minutes from the towering sandstone cliffs of Zion National Park, an unexpected wellness oasis has emerged in the quiet town of La Verkin, Utah. The newly opened Zion Canyon Hot Springs is bringing over 50 geothermal and mineral-rich pools to the desert plateau, including some that mimic the healing waters of faraway destinations like Iceland's Blue Lagoon and the Dead Sea. The pools are fed by the legendary La Verkin Sulphur Springs (aka Pah Tempe) and set against a healing backdrop of crimson canyons and endless sky. Just 30 minutes to the east sprawls Zion National Park, the second most visited U.S. national park in 2024. "It was such an honor to be approached by La Verkin to create this destination and reopen public access to these special waters in recognition of our success launching Iron Mountain Hot Springs in Glenwood Springs, Colorado,' Steve Beckley, co-founder of WorldSprings, said in a press release shared with Travel + Leisure. WorldSprings already operates hot springs in Dallas and the aforementioned facility Glenwood Springs, Colorado, but the new Zion Canyon Hot Springs is its largest property. 'We're excited to open what will be a premier hot springs destination in the U.S. and welcome guests to an oasis where they can relax, rejuvenate, and connect with nature,' Ronald Neumann, the general manager and vice president of Zion Canyon Hot Springs, said in the press release. In addition to providing access to natural hot spring water surrounded by some of the nation's most renowned red-rock views, a day at Zion Canyon Hot Springs is a full-body journey with cold plunges, barrel saunas, an on-site eatery, and a family-friendly freshwater pool. The geothermal pools range between 88 degrees to 104 degrees, with a natural mineral makeup that is said to reduce stress, improve sleep, and enhance recovery. The facility's 16 WorldSprings pools mimic the mineral content of iconic hot springs around the globe, allowing Utah visitors to experience the natural waters of Japan, Guatemala, and New Zealand, among others. Zion Canyon Hot Springs is split into a family and adult-only section. Both sections have natural hot spring pools and barrel saunas, but the family side has a large freshwater pool and a whirlpool, while the adult's side has cold plunges and the 16 WorldSprings-inspired pools. The water is sourced from local natural hot springs that produce around seven million gallons of 107-degree water daily, according to the county water district. Rates for Zion Canyon Hot Springs start at $49 for the adult-only side of the facility and $39 for the family-friendly section. A three-hour reservation to the family section starts at $25 for kids under the age of 13. There are also cabana and towel rentals. For locals, there are season passes with unlimited visits available. Zion Canyon Hot Springs is open daily 7 days per week from 10 a.m to 10 p.m. Read the original article on Travel & Leisure

Samsung Is Running Seven Serious Deals For The Galaxy Z Fold 7
Samsung Is Running Seven Serious Deals For The Galaxy Z Fold 7

Forbes

time30 minutes ago

  • Forbes

Samsung Is Running Seven Serious Deals For The Galaxy Z Fold 7

The Samsung Galaxy Z Fold7 smartphone is displayed at a Samsung store in Seoul on July 10, 2025. ... More Samsung unveiled on July 9, the new generation of its foldable smartphone, the Z Fold7, dramatically slimmed down in an attempt to jumpstart this still-niche market. (Photo by Jung Yeon-je / AFP) (Photo by JUNG YEON-JE/AFP via Getty Images) Samsung really wants you to buy the Galaxy Z Fold 7. It started with repeated teasers, that virtually gave everything away, and ended with a spate of pre-order discounts, including a 24-hour flash giveaway. As it stands, the Korean company is running seven (get it?) different promotions for its Galaxy Z Fold 7, alongside a new double trade-in deal I haven't seen before (more on that below). Here's what is on offer. Most of these offers expire on July 24th, except the long-running "APP5" code, and the free pair of Galaxy Buds voucher, which ends today (July 15th) at midnight. Considering Samsung continued to offer freebies and discounts weeks after the Galaxy S25 Edge released, I wouldn't be surprised if more were on the way for the Fold 7. These promotions and freebies, before a trade-in is included, total £718.95 ($963.08). A solid deal that almost makes buying the phone in the pre-order period worth it. Especially the double trade-in deal, which is one of the more eye-catching offers. In essence, Samsung will pay £200 for 'any tablet in any condition' on top of your used-smartphone trade-in. The Korean company previously told me that it will honor that promise of accepting any device, and the small print doesn't have any glaring caveats to it. The 100 day try before you buy period, too, is very enticing. Samsung Has More Galaxy Z Fold 7 Discounts Up Its Sleeve But, as you will know if you read my deals stories (don't miss any by hitting the follow button below), this is the worst time to buy a smartphone. Like cars, smartphones depreciate rapidly and the pre-order period is when the device is at its most expensive. Samsung will almost certainly discount the Galaxy Z Fold 7 again. A good cue is the Galaxy S25 Edge, which was bundled with the Galaxy Tab A9 Plus a month after the phone launched. Also, a Galaxy Z Fold 6 deal in May knocked a straight $350 off the device, which, to me, is the gold standard in deals because the actual price of the handset is lower. Freebies and incentives are great, but minimising the dent in your wallet is far more important. Trade-in prices, too, were better a month ago. In June Samsung valued the Galaxy S23 Plus at £333 ($446.08), but now it's only worth £257 ($344.27). The Galaxy S23 Ultra was priced at £449 ($601.47), now it's valued at £386 ($517.07). It's not all bad news, last month Samsung paid £230 ($308.10) for the Apple iPhone 13 Pro Max, that valuation has now shot up to £345 ($462.15). If you're not in a hurry to buy the Galaxy Z Fold 7, I'd say it's worth waiting to see what discounts Samsung has up its sleeve for next month.

Strategic Collaborations and Local Innovations Reshape the $24.58 Billion Market
Strategic Collaborations and Local Innovations Reshape the $24.58 Billion Market

Yahoo

time35 minutes ago

  • Yahoo

Strategic Collaborations and Local Innovations Reshape the $24.58 Billion Market

The Asia Pacific diabetes market is set for growth, expected to expand annually by 8.8% to reach $24.58 billion by 2025. Significant trends include increased diabetes prevalence and digital health adoption, driving demand for monitoring and therapeutic solutions. Enhanced policy reforms and insurance coverage are fostering market access, while rising competition is reshaping the landscape with strategic alliances and localized innovation. The comprehensive report analyzes diagnosis and monitoring devices and therapeutics, exploring market dynamics and opportunities. Get insights on the competitive environment, segment growth, and investment potential within the diabetes market in Asia Pacific. Asia-Pacific Diabetes Devices and Therapeutics Market Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update" report has been added to diabetes market in Asia Pacific is expected to grow by 8.8% on annual basis to reach US$24.58 billion in 2025. The diabetes market in the region has experienced robust growth during 2020-2024, achieving a CAGR of 9.4%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.4% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 22.59 billion to approximately USD 35.43 billion. This report provides a detailed data-centric analysis of the diabetes industry in Asia Pacific, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics. The market features participation from both established multinational corporations and emerging regional manufacturers. The competitive environment is characterized by varied regulatory frameworks and economic conditions across the Asia Pacific. Publications from the past 12 months indicate a segmented market with regional differentiation in product offerings and market strategies. The market is evolving with a mix of longstanding multinational entities and agile local innovators. With an expected trend toward consolidation and strategic collaborations, the next 2-4 years will likely see a reshaping of competitive dynamics focused on localized product innovation and regulatory alignment. The diabetes devices and therapeutics market in Asia Pacific is being reshaped by increased diabetes prevalence, the adoption of digital health solutions, and evolving policy frameworks. These drivers are expected to intensify over the next 2-4 years, leading to more targeted and data-supported approaches in managing diabetes across diverse regional Rising Diabetes Prevalence and Healthcare Demand Recent publications (2023-2024) report a measurable increase in diabetes cases across Asia Pacific, with significant examples in China, India, and several Southeast Asian nations. Rising incidences of type 2 diabetes are increasing the need for effective monitoring and therapeutic interventions. Demographic shifts (aging populations, urbanization) and evolving lifestyle patterns drive the demand. Adjustments in healthcare financing and insurance reforms across the region support wider access to diagnostic devices and therapies. Anticipate a steady intensification in demand for devices that integrate daily management tools. Healthcare systems will likely expand investments in diabetes-related technologies to address the growing burden. Leverage Digital Integration and Remote Monitoring Solutions Recent regional studies highlight the increased adoption of continuous glucose monitoring (CGM) systems and telehealth services, especially in Japan and South Korea. Various Asia Pacific markets have initiated pilot programs integrating remote monitoring with traditional care models. Technological progress and supportive regulatory policies in digital health are key drivers. Increased investments in digital infrastructure by governments and insurers foster the adoption of connected devices. Expect further penetration of digital health solutions, with remote monitoring playing a more central role in clinical decision-making. Enhanced data analytics are likely to support more personalized diabetes management strategies regionally. Activate Policy Reforms and Insurance Coverage Enhancements Recent reforms in countries like Singapore and Australia have expanded reimbursement for diabetes management devices. Publications from late 2023 detail shifts in regulatory frameworks that now favor broader insurance coverage for innovative therapeutics. Government initiatives focused on reducing long-term healthcare expenditures and improving chronic disease management drive policy changes. Broader insurance reforms align with healthcare objectives to support preventive care and early intervention. The convergence of supportive policies and insurance incentives will further facilitate market access for new devices and therapies. Ongoing regulatory clarifications will likely encourage domestic and international investments in the region. Map Key Players and New Entrants Major global companies continue investing in research and development to maintain their regional presence. Local manufacturers, particularly in India and China, are entering the market with products tailored to regional cost structures and clinical needs. New entrants are leveraging localized expertise to address gaps in the current market, supported by regional demand for cost-effective solutions. Evaluate Strategic Collaborations and Market Consolidation Recent transactions in the last 12 months have seen collaborations between device manufacturers and healthcare providers in Southeast Asia and Australia. Strategic alliances emerge as companies seek to expand their product portfolios and market reach through mergers and acquisitions. The competitive landscape will likely experience increased consolidation as larger players acquire or partner with regional innovators. Firms that successfully navigate regulatory requirements and invest in localized development are positioned to gain competitive advantages. Forecast Competitive Shifts Continued regulatory reforms and heightened demand for diabetes management solutions will attract further competition. Specialized product developments addressing country-specific needs may lead to a more segmented competitive environment. Investment in research, strategic partnerships, and adaptation to local regulatory environments will be critical for sustaining market leadership. A bundled offering, combining the following 12 reports, covering 480 tables and 648 figures: Asia Pacific Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Australia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) China Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) India Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Indonesia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Japan Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Malaysia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Philippines Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Singapore Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) South Korea Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Taiwan Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Thailand Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook) Scope for Each Report Diabetes Devices and Therapeutics Market Share by Category Diagnosis and Monitoring Devices Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices Blood Glucose Monitoring Devices Insulin Delivery Devices Diabetes Management and Mobile Applications Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices Self-Monitoring Blood Glucose Devices Continuous Blood Glucose Monitoring Devices Test Strips Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices Insulin Pumps Insulin Pens Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics Oral Anti-Diabetic Drugs Insulin Non-Insulin Injectable Drugs Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs Alpha-Glucosidase Inhibitors DPP-4 Inhibitors SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin Basal or Long-Acting Bolus or Fast-Acting Traditional Human Insulin Drugs Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs GLP-1 Receptor Agonists Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs Combination Insulin Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration Subcutaneous Intravenous Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes Type 1 Diabetes Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels Online Pharmacies Hospital Pharmacies Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User Hospitals Diabetes Clinics Homecare Reasons to buy Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user. Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly. Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation. Key Attributes: Report Attribute Details No. of Pages 840 Forecast Period 2025 - 2029 Estimated Market Value (USD) in 2025 $26.63 Billion Forecasted Market Value (USD) by 2029 $35.43 Billion Compound Annual Growth Rate 7.4% Regions Covered Asia Pacific For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Asia-Pacific Diabetes Devices and Therapeutics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store